Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Galectins | 5 | 2023 | 71 | 2.280 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 3 | 2022 | 59 | 1.420 |
Why?
|
| Programmed Cell Death 1 Receptor | 5 | 2023 | 1048 | 0.790 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2021 | 19 | 0.780 |
Why?
|
| Cell Death | 1 | 2022 | 671 | 0.700 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 541 | 0.620 |
Why?
|
| Immunity | 1 | 2017 | 342 | 0.530 |
Why?
|
| T-Lymphocytes | 4 | 2023 | 3869 | 0.510 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 1390 | 0.440 |
Why?
|
| Immunotherapy | 4 | 2023 | 3341 | 0.420 |
Why?
|
| Neoplasms | 5 | 2023 | 15193 | 0.350 |
Why?
|
| B7-H1 Antigen | 3 | 2023 | 1022 | 0.280 |
Why?
|
| Melanoma | 1 | 2023 | 5317 | 0.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8873 | 0.250 |
Why?
|
| Jurkat Cells | 2 | 2021 | 311 | 0.230 |
Why?
|
| Ataxia Telangiectasia | 1 | 2023 | 62 | 0.220 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 7789 | 0.210 |
Why?
|
| Casein Kinase II | 1 | 2022 | 69 | 0.210 |
Why?
|
| Receptors, Immunologic | 1 | 2023 | 309 | 0.200 |
Why?
|
| Leukemia, T-Cell | 1 | 2020 | 87 | 0.180 |
Why?
|
| Tumor Microenvironment | 4 | 2023 | 2864 | 0.180 |
Why?
|
| Melanoma, Experimental | 1 | 2021 | 368 | 0.160 |
Why?
|
| Exosomes | 1 | 2021 | 253 | 0.160 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 582 | 0.160 |
Why?
|
| Models, Immunological | 1 | 2017 | 77 | 0.150 |
Why?
|
| Antibodies | 1 | 2021 | 838 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 673 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 2314 | 0.140 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 1016 | 0.130 |
Why?
|
| Ligands | 1 | 2017 | 995 | 0.130 |
Why?
|
| Antineoplastic Agents, Immunological | 2 | 2021 | 1249 | 0.120 |
Why?
|
| Protein Binding | 1 | 2021 | 3438 | 0.120 |
Why?
|
| Animals | 7 | 2023 | 59536 | 0.120 |
Why?
|
| Signal Transduction | 3 | 2021 | 11965 | 0.110 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 661 | 0.110 |
Why?
|
| Mice | 6 | 2023 | 34495 | 0.100 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2021 | 1215 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2021 | 9180 | 0.090 |
Why?
|
| Humans | 10 | 2023 | 261506 | 0.090 |
Why?
|
| Lymphocyte Activation | 2 | 2021 | 1688 | 0.070 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 4654 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 2027 | 0.060 |
Why?
|
| Anthracyclines | 1 | 2023 | 331 | 0.050 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2023 | 430 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 14289 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 11538 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2023 | 726 | 0.040 |
Why?
|
| Glycosylation | 1 | 2020 | 213 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2021 | 242 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2021 | 675 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 538 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 905 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 733 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2023 | 3005 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 992 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2022 | 1085 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2020 | 1869 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 1489 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 15694 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2022 | 4804 | 0.030 |
Why?
|
| Models, Biological | 1 | 2021 | 3254 | 0.030 |
Why?
|
| Biomarkers | 1 | 2021 | 5047 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2330 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 3251 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2016 | 2295 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 4557 | 0.010 |
Why?
|
| Female | 2 | 2021 | 141928 | 0.010 |
Why?
|